去年，Sarepta Therapeutics Inc表现最佳的业务板块PMO Products实现营收965.57M美元。United States的营收贡献最高，去年达到1.70B美元。最近一个季度，截至2026-06-30，Sarepta Therapeutics Inc表现最佳的业务板块PMO Products实现营收230.56M美元。United States的营收贡献最高，达到296.73M美元。

业务

营业收入

占比

年报

年报

单季报

PMO Products

ELEVIDYS

collaboration and other

FY2025

FY2024

FY2023

PMO Products

965.57M(43.92%)

967.17M(50.85%)

944.52M(75.97%)

ELEVIDYS

898.73M(40.88%)

820.79M(43.15%)

200.36M(16.11%)

collaboration and other

333.94M(15.19%)

114.02M(5.99%)

98.46M(7.92%)

地区

营业收入

占比

年报

年报

单季报

United States

Rest of World

FY2025

FY2024

FY2023

United States

1.70B(91.14%)

1.64B(91.60%)

998.30M(87.20%)

Rest of World

165.18M(8.86%)

150.25M(8.40%)

146.58M(12.80%)